Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study.
Little is known about prevalence, awareness, and control of familial hypercholesterolemia (FH) in the United States.



To address these knowledge gaps, we developed an ePhenotyping algorithm for rapid identification of FH in electronic health records (EHRs) and deployed it in the Screening Employees And Residents in the Community for Hypercholesterolemia (SEARCH) study.



We queried a database of 131,000 individuals seen between 1993 and 2014 in primary care practice to identify 5992 (mean age 52 ± 13 years, 42% men) patients with low-density lipoprotein cholesterol (LDL-C) ≥190 mg/dL, triglycerides <400 mg/dL and without secondary causes of hyperlipidemia.



Our EHR-based algorithm ascertained the Dutch Lipid Clinic Network criteria for FH using structured data sets and natural language processing for family history and presence of FH stigmata on physical examination. Blinded expert review revealed positive and negative predictive values for the SEARCH algorithm at 94% and 97%, respectively. The algorithm identified 32 definite and 391 probable cases with an overall FH prevalence of 0.32% (1:310). Only 55% of the FH cases had a diagnosis code relevant to FH. Mean LDL-C at the time of FH ascertainment was 237 mg/dL; at follow-up, 70% (298 of 423) of patients were on lipid-lowering treatment with 80% achieving an LDL-C ≤100 mg/dL. Of treated FH patients with premature CHD, only 22% (48 of 221) achieved an LDL-C ≤70 mg/dL.



In a primary care setting, we found the prevalence of FH to be 1:310 with low awareness and control. Further studies are needed to assess whether automated detection of FH in EHR improves patient outcomes.
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
Maya S
MS
Safarova
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Hongfang
H
Liu
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA. Electronic address: Kullo.Iftikhar@mayo.edu.
Iftikhar J
IJ
Kullo
D000328:Adult; D000368:Aged; D000465:Algorithms; D008078:Cholesterol, LDL / Q000097:blood; D016208:Databases, Factual; D057286:Electronic Health Records; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000175:diagnosis* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D015995:Prevalence; D014280:Triglycerides / Q000097:blood
D008078:Cholesterol, LDL; D014280:Triglycerides
Awareness; Control; Electronic health records; Electronic phenotyping; Familial hypercholesterolemia; Hypercholesterolemia; Informatics; Prevalence; Screening; eEpidemiology
BMJ. 2000 Jul 15;321(7254):148
10894692
Genet Med. 2013 Oct;15(10):761-71
23743551
Eur Heart J. 2015 Mar 1;36(9):566-75
24366918
Mayo Clin Proc. 2016 Jun;91(6):770-86
27261867
Eur Heart J. 2016 May 01;37(17):1384-94
26908947
Crit Care Med. 2015 Jun;43(6):1276-82
25756413
Am J Epidemiol. 2004 Sep 1;160(5):421-9
15321838
Atherosclerosis. 2015 Jan;238(1):64-9
25437892
J Clin Lipidol. 2011 Jun;5(3 Suppl):S9-17
21600530
J Biomed Inform. 2009 Oct;42(5):839-51
19435614
J Clin Lipidol. 2011 Jun;5(3 Suppl):S1-8
21600525
J Am Med Inform Assoc. 2013 Jun;20(e1):e147-54
23531748
Atherosclerosis. 1999 Jan;142(1):105-12
9920511
J Med Genet. 2014 Aug;51(8):537-44
24987033
Eur Heart J. 2013 Dec;34(45):3478-90a
23956253
Healthcare (Basel). 2015;3(3):830-7
26636032
Lancet. 2015 Jan 24;385(9965):331-40
25282519
Am J Cardiol. 2012 Sep 15;110(6):823-5
22658245
Atherosclerosis. 2005 May;180(1):155-60
15823288
J Am Med Inform Assoc. 2013 Dec;20(e2):e349-54
24166724
Proc AMIA Symp. 2001;:105-9
11825163
Ann Allergy Asthma Immunol. 2013 Nov;111(5):364-9
24125142
AMIA Jt Summits Transl Sci Proc. 2013 Mar 18;2013:149-53
24303255
Popul Health Manag. 2015 Apr;18(2):79-85
25290223
Expert Rev Cardiovasc Ther. 2008 Apr;6(4):567-81
18402545
J Am Med Inform Assoc. 2010 Sep-Oct;17(5):568-74
20819866
Circulation. 2016 Mar 15;133(11):1067-72
26976914
Heart Lung Circ. 2014 Apr;23(4):309-13
24054707
J Am Med Inform Assoc. 2010 Sep-Oct;17(5):507-13
20819853
Atherosclerosis. 2004 Mar;173(1):55-68
15177124
J Clin Endocrinol Metab. 2012 Nov;97(11):3956-64
22893714
J Clin Lipidol. 2013 Nov-Dec;7(6):546-60
24314354
Stud Health Technol Inform. 2015;216:604-8
26262122
Am J Public Health. 2014 Dec;104(12):e12-22
25322302
J Clin Invest. 1973 Jul;52(7):1544-68
4718953
Nature. 2010 Aug 5;466(7307):707-13
20686565
BMJ. 2008 Nov 11;337:a2423
19001495
Cardiovasc Drugs Ther. 2014 Jun;28(3):281-9
24842558
Am Heart J. 2014 Mar;167(3):342-349.e17
24576518
Eur Heart J. 2015 Mar 1;36(9):560-5
24585268
Circ Cardiovasc Genet. 2016 Jun;9(3):240-9
27013694
Nat Clin Pract Cardiovasc Med. 2007 Aug;4(8):404-5
17593912
Lancet. 2013 Jan 5;381(9860):40-6
23122768
Prev Chronic Dis. 2009 Jan;6(1):A33
19080039